Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Succeeder TechnologySHSE:688338 -5.05%86 Quick Ratio is 20.17 as of Mar. 2026, which is 36% above its 10-year median of 14.83. GuruFocus rates SHSE:688338 with a GF Score™ of 86/100 and a GF Value™ of ¥30.43 (Fairly Valued). The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Beijing Succeeder Technology ranks better than 98.13% on this metric.
Beijing Succeeder Technology has a quick ratio of 20.17. It generally indicates good short-term financial strength.
The historical rank and industry rank for Beijing Succeeder Technology's Quick Ratio or its related term are showing as below:
SHSE:688338'
s Quick Ratio Range Over the Past 10 Years
Min: 1.97 Med: 14.83 Max: 34.03
Current: 20.17
During the past 10 years, Beijing Succeeder Technology's highest Quick Ratio was 34.03. The lowest was 1.97. And the median was 14.83.
SHSE:688338's Quick Ratio is ranked better than 98.13% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.89
vs SHSE:688338: 20.17
Beijing Succeeder Technology (SHSE:688338) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Beijing Succeeder Technology Quick Ratio Related Terms
Beijing Succeeder Technology Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688338 vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Beijing Succeeder Technology's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Succeeder Technology Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Succeeder Technology's Quick Ratio falls into.
Beijing Succeeder Technology Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Succeeder Technology (SHSE:688338) has a Quick Ratio of 20.17 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Beijing Succeeder Technology and its competitors. This is 36% above median its historical median of 14.83. Over the past decade, Beijing Succeeder Technology's Quick Ratio has ranged from 1.97 to 34.03. According to the industry distribution chart, Beijing Succeeder Technology ranks #16 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Beijing Succeeder Technology's Quick Ratio too high?
Beijing Succeeder Technology's current Quick Ratio of 20.17 is 36% above median its 10-year median of 14.83. Over the past 10 years, this metric has ranged from a low of 1.97 to a high of 34.03. The Medical Devices & Instruments industry median Quick Ratio is 1.89. Beijing Succeeder Technology's value of 20.17 is 967.2% above this industry median. Based on the distribution chart, Beijing Succeeder Technology ranks #16 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Succeeder Technology has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Succeeder Technology ranks #16 out of 854 companies for Quick Ratio. This places Beijing Succeeder Technology in the top 2% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. Beijing Succeeder Technology's value of 20.17 is 967.2% above this benchmark. Historically, Beijing Succeeder Technology's own Quick Ratio has ranged from 1.97 to 34.03 over the past decade. While the company's 10-year median is 14.83 vs. the industry median of 1.89, Beijing Succeeder Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Succeeder Technology's current Quick Ratio of 20.17 is 967.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Beijing Succeeder Technology and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Succeeder Technology's current Quick Ratio is 20.17, which is 36% above median its own 10-year median of 14.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.43, compared to a current price of ¥29.13 — trading 4.3% below its estimated fair value. The current Quick Ratio is 20.17, which is 36% above median its 10-year median of 14.83 and 967.2% above the Medical Devices & Instruments industry median of 1.89. Beijing Succeeder Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current Quick Ratio is 20.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued.
The current stock price of ¥29.13 is trading 4.3% below its estimated GF Value™ of ¥30.43.
GuruFocus considers Beijing Succeeder Technology to be Fairly Valued.
Key valuation signals for SHSE:688338:
Quick Ratio: 20.17 (36% above median its 10-year median of 14.83)
GF Value™: ¥30.43 vs. price of ¥29.13 (4.3% below fair value)
Industry Position: 967.2% above the Medical Devices & Instruments median (#16 of 854)
No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
86GF Score
Get the complete analysis for SHSE:688338
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688338 has been successfully added to your 
